“Real World Assessment of Once-a-Month Dosing of Lebrikizumab in Commercial Claims”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s747. Accessed April 30, 2026. https://skin.dermsquared.com/skin/article/view/4118.